{"doi":"10.1073/pnas.2111405119","title":"Parkinson’s disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein–induced changes in maturation and immune reactive properties","abstract":"<jats:title>Significance</jats:title>\n                  <jats:p>Our results demonstrate the existence of early cellular pathways and network alterations in oligodendrocytes in the alpha-synucleinopathies Parkinson’s disease and multiple system atrophy. They further reveal the involvement of an immune component triggered by alpha-synuclein protein, as well as a connection between (epi)genetic changes and immune reactivity in multiple system atrophy. The knowledge generated in this study could be used to devise novel therapeutic approaches to treat synucleinopathies.</jats:p>","journal":"Proceedings of the National Academy of Sciences","year":2022,"id":646205,"datarank":0.5897738449086489,"base_score":3.9318256327243257,"endowment":3.9318256327243257,"self_citation_contribution":0.5897738449086489,"citation_network_contribution":0.0,"self_endowment_contribution":0.5897738449086489,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":50,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1682995,"name":"Gabriel Teku","orcid":null,"position":1,"is_corresponding":false},{"id":210746,"name":"Yuriy Pomeshchik","orcid":"0000-0002-1412-7403","position":2,"is_corresponding":false},{"id":1682996,"name":"Juan F. Reyes","orcid":"0000-0002-6361-534X","position":3,"is_corresponding":false},{"id":1682997,"name":"Margarita Chumarina","orcid":null,"position":4,"is_corresponding":false},{"id":1682998,"name":"Kaspar Russ","orcid":"0000-0002-4049-3319","position":5,"is_corresponding":false},{"id":1682999,"name":"Ekaterina Savchenko","orcid":"0000-0002-5932-1648","position":6,"is_corresponding":false},{"id":1683000,"name":"Anna Hammarberg","orcid":"0000-0002-7724-1430","position":7,"is_corresponding":false},{"id":1683001,"name":"Nuno Jorge Lamas","orcid":"0000-0002-4648-136X","position":8,"is_corresponding":false},{"id":210748,"name":"Anna Collin","orcid":null,"position":9,"is_corresponding":false},{"id":1213384,"name":"Gunnar K. Gouras","orcid":"0000-0002-5500-6325","position":10,"is_corresponding":false},{"id":1683002,"name":"Oxana Klementieva","orcid":"0000-0003-1782-050X","position":11,"is_corresponding":false},{"id":1443592,"name":"Martin Hallbeck","orcid":"0000-0001-6716-0314","position":12,"is_corresponding":false},{"id":1235817,"name":"Ricardo Taipa","orcid":"0000-0002-9260-0227","position":13,"is_corresponding":false},{"id":681470,"name":"Mauno Vihinen","orcid":"0000-0002-9614-7976","position":14,"is_corresponding":false},{"id":210752,"name":"Laurent Roybon","orcid":null,"position":15,"is_corresponding":false},{"id":1682994,"name":"Carla Azevedo","orcid":"0000-0003-3909-8984","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Parkinson’s disease and multiple system atrophy patient iPSC-derived oligodendrocytes exhibit alpha-synuclein–induced changes in maturation and immune reactive properties","abstract":"<jats:title>Significance</jats:title>\n                  <jats:p>Our results demonstrate the existence of early cellular pathways and network alterations in oligodendrocytes in the alpha-synucleinopathies Parkinson’s disease and multiple system atrophy. They further reveal the involvement of an immune component triggered by alpha-synuclein protein, as well as a connection between (epi)genetic changes and immune reactivity in multiple system atrophy. The knowledge generated in this study could be used to devise novel therapeutic approaches to treat synucleinopathies.</jats:p>","is_dataset_classified":null,"base_score":3.9318256327243257,"endowment":3.9318256327243257,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"35294277","pmcid":"PMC8944747","openalex_id":"https://openalex.org/W4221108487","authors":[],"funders":[{"funder_name":"Vetenskapsrådet","grant_id":"VR-2015-03684","title":null},{"funder_name":"Vetenskapsrådet","grant_id":"VR-2121-02284","title":null},{"funder_name":"Telethon","grant_id":"GTB12001","title":null},{"funder_name":"Swedish Research Council","grant_id":"unidentified","title":"unidentified"}],"total_grants":4,"fwci":6.336,"citation_percentile":0.97520573,"influential_citations":0,"citation_trend":[{"year":2022,"count":4},{"year":2023,"count":27},{"year":2024,"count":8},{"year":2025,"count":5},{"year":2026,"count":6}],"oa_status":"green","license":"other-oa","oa_locations":[{"url":"http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-184265","host_type":"repository"},{"url":"http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-184265","host_type":"repository"},{"url":"https://pnas.org/doi/pdf/10.1073/pnas.2111405119","host_type":"publisher"},{"url":"https://doi.org/10.1073/pnas.2111405119","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/35294277","host_type":"repository"},{"url":"https://lup.lub.lu.se/record/37db1437-e858-44e2-bfb7-e121ccac07d3","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8944747","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC8944747","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC8944747?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.1073/pnas.2111405119","host_type":""}],"fields_of_study":["Parkinson's Disease Mechanisms and Treatments","Nerve injury and regeneration","Nuclear Receptors and Signaling","0301 basic medicine","0303 health sciences","03 medical and health sciences","Humans","Induced Pluripotent Stem Cells","Multiple System Atrophy","Oligodendroglia","Parkinson Disease","Synucleinopathies","alpha-Synuclein"],"mesh_terms":["Synucleinopathies","Humans","Oligodendroglia","Parkinson Disease","Multiple System Atrophy","alpha-Synuclein","Induced Pluripotent Stem Cells"],"keywords":["Synucleinopathies","Atrophy","Parkinson's disease","Alpha-synuclein","Immune system","Neuroscience","Neuroinflammation","Biology","Disease","Immunology","Medicine","Pathology","Inflammation","Genetics","Maturation","HLA","Transcriptome","Oligodendrocytes","oligodendrocytes; transcriptome; alpha-synuclein; maturation; HLA","Induced Pluripotent Stem Cells","Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)","Parkinson Disease","Biological Sciences","Multiple System Atrophy","Oligodendroglia","Humans","Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-09T12:09:26.130234Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}